We are live on
!
Find out more
WC
Woodstock Corp Portfolio holdings
AUM
$1.2B
1-Year Est. Return
26.37%
This Fund
S&P 500
This Quarter
Est. Return
-3.71%
1 Year Est. Return
+26.37%
3 Year Est. Return
+96.13%
5 Year Est. Return
+140.78%
10 Year Est. Return
+511.51%
AUM
$797M
AUM Growth
-$50M
(-5.9%)
Cap. Flow
-$11M
Cap. Flow
% of AUM
-1.38%
Top 10 Holdings %
Top 10 Hldgs %
35.2%
Holding
175
New
5
Increased
39
Reduced
64
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DexCom
DXCM
|
+$1.42M |
| 2 |
Chevron
CVX
|
+$817K |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$737K |
| 4 |
Harmony Biosciences
HRMY
|
+$408K |
| 5 |
Flowserve
FLS
|
+$313K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$2.8M |
| 2 |
CVS Health
CVS
|
+$2.35M |
| 3 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
+$1.46M |
| 4 |
NVIDIA
NVDA
|
+$1.21M |
| 5 |
PDCE
PDC Energy, Inc.
PDCE
|
+$1.07M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.53% |
| 2 | Healthcare | 19.84% |
| 3 | Consumer Discretionary | 9.26% |
| 4 | Industrials | 7.51% |
| 5 | Consumer Staples | 7.46% |
Similar funds
SGDR
VC
RCYC
WC
FCCPG
HCM
MB
GP
Woodstock Corp's Q3 2023 Portfolio in Review
As of Q3 2023, Woodstock Corp held 175 positions worth $797M, down 5.9% from $847M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Woodstock Corp's Q3 2023 filing shows 5 new, 39 increased, 64 reduced and 7 closed positions. Its largest new stake was Harmony Biosciences: 11,761 shares worth $385K. The largest sale was Bristol-Myers Squibb, an estimated $2.8M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 28% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Woodstock Corp's largest Q3 2023 buy was Harmony Biosciences: 11,761 shares worth $385K.
- Woodstock Corp added most to DexCom in Q3 2023, an estimated $1.42M increase.
- Woodstock Corp's biggest Q3 2023 reduction was Bristol-Myers Squibb, cutting an estimated $2.8M.
- Woodstock Corp fully exited Reata Pharmaceuticals, Inc. Class A Common Stock in Q3 2023, selling an estimated $1.46M.
- Woodstock Corp's ten largest holdings make up 35% of its $797M portfolio in Q3 2023.
- Woodstock Corp opened 5 new positions and closed 7 in Q3 2023.
- Woodstock Corp's portfolio value fell 5.9% quarter-over-quarter to $797M.
Based on Woodstock Corp's 13F filing for Q3 2023, filed 10 Oct 2023.